CD274 and melanoma: Our results might have limitations such as a limited sampling, the lack of consensus method in the evaluation of PD-L1 expression (only quantitative in our study), not considering more categories of positivity depending on the amount and distribution of positive melanoma cells, and the fact that the immunohistochemical tests were performed on tissue fragments prior to any treatment.